CAMT CAMTEK LTD
Optical Instruments & Lenses · Nasdaq · SEC CIK 1109138 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY15.6%
TTM net income YoY-57.2%
TTM EPS YoY-57.0%
Revenue 3-yr CAGR15.6%
Net income 3-yr CAGR-14.1%
Margins
Gross margin50.5%
Operating margin25.8%
Net margin10.2%
FCF margin25.7%
EBITDA margin28.2%
Returns
ROE8.7%
ROA4.7%
ROIC (approx.)28.8%
Asset turnover0.46x
Leverage & solvency
Liabilities / assets51.0%
Debt / equity0.00x
Current ratio8.35x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.80x
Accruals ratio-8.5%
Payout ratio—
Capex / revenue2.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 · USD | FY20242024-12-31 · USD |
|---|---|---|
| Income statement | ||
| Revenue | $496.07M | $429.23M |
| Cost of revenue | $245.75M | $219.28M |
| Gross profit | $250.32M | $209.95M |
| R&D expense | $48.34M | $38.29M |
| SG&A expense | $73.77M | $63.59M |
| Operating income | $128.20M | $108.07M |
| Pretax income | $52.34M | $131.24M |
| Income tax | $1.61M | $12.72M |
| Net income | $50.72M | $118.52M |
| EBITDA | $139.98M | $118.73M |
| EPS (basic) | 1.11 | 2.62 |
| EPS (diluted) | 1.04 | 2.42 |
| Dividends declared per share | — | 1.33ILS |
| Weighted avg. shares (diluted) | 49,970 | 49,369 |
| Banking | ||
| Provision for credit losses | $11,000 | $34,000 |
| Balance sheet | ||
| Cash & equivalents | $177.85M | $126.22M |
| Short-term investments | $78.86M | $30.81M |
| Receivables | $90.83M | $99.47M |
| Inventory | $112.20M | $111.20M |
| Current assets | $897.00M | $620.06M |
| PP&E, net | $65.11M | $54.20M |
| Goodwill | $74.34M | $74.34M |
| Intangibles | $10.06M | $13.36M |
| Total assets | $1.26B | $892.04M |
| Current liabilities | $107.42M | $123.91M |
| Total liabilities | $642.83M | $342.81M |
| Shareholders' equity | $617.00M | $549.24M |
| Shares outstanding | 45.83M | 45.45M |
| Cash flow statement | ||
| Operating cash flow | $141.87M | $122.24M |
| Capital expenditure | $14.40M | $10.10M |
| Free cash flow | $127.47M | $112.14M |
| Investing cash flow | -$310.32M | -$55.91M |
| Financing cash flow | $218.99M | -$60.05M |
| Depreciation & amortization | $11.78M | $10.67M |
| Stock-based compensation | $16.89M | $14.50M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· This company uses different currencies across periods or line items (e.g. USD convenience translations in annual reports). Each column header shows its currency and cells in a different currency are marked; do not compare figures across currencies. Charts use only periods in the latest period's currency.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.